Clinical Trials Directory

Trials / Unknown

UnknownNCT02015962

Comparison of Enteral Versus Intravenous Potassium Supplementation

Comparison of Enteral Versus Intravenous Potassium Supplementation in Hypokalemia in Post Cardiac Surgery Pediatric Cardiac Intensive Care Patients - Prospective Open Label Randomized Control Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Aga Khan University · Academic / Other
Sex
All
Age
1 Day – 25 Years
Healthy volunteers
Not accepted

Summary

Null hypothesis: There is no difference in the efficacy of IVPR and EPR during an episode of hypokalemia. Alternate Hypothesis: There is a mean difference of 15% in Serum Potassium levels between the two groups. Objective: To compare the efficacy EPR and IVPR for treatment of hypokalemia (measured as change in serum potassium levels in milliequivalent/L after potassium replacement)

Detailed description

Hypokalemia is frequently encountered in daily clinical practices of cardiac intensive care unit (CICU). The development of ventricular arrhythmias related to hypokalemia can lead to sudden cardiac death. Thus, potassium replacement therapy is the cornerstone therapy for hypokalemia.Though intravenous potassium replacement (IVPR) in hypokalemia is the preferred route in most intensive care settings, it is associated with known safety risks. Inappropriately administered, IVPR can lead to arrhythmias, cardiac arrest and death 1, 7, 8. Given these risks, IVPR is considered a "high-alert medication" by Institute of Safe Medication practice. Enteral potassium replacement (EPR), with its superior safety profile may be a better alternative to IVPR. A retrospective review showed that the efficacy of EPR was comparable to IVPR in pediatric patients after congenital heart disease. The investigators seek to explore this comparison between EPR and IVPR in a randomized prospective trial

Conditions

Interventions

TypeNameDescription
DRUGIntravenous potassium chloride
DRUGOral potassium chloride

Timeline

Start date
2013-10-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2013-12-19
Last updated
2013-12-19

Locations

3 sites across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT02015962. Inclusion in this directory is not an endorsement.